{"url_path":"/sec/bdsx/8-k/2026-05-20/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1439725/0001193125-26-232631-index.html","accession_number":"0001193125-26-232631","cik":"0001439725","ticker":"BDSX","issuer_name":"BIODESIX INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1439725/0001193125-26-232631-index.html","primary_entity_key":"0001439725","primary_entity_name":"BIODESIX INC"},"word_count":77,"has_tables":true,"body_markdown":"Item 9.01.\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\nNo.\n\n  \n\nDescription\n\n104\n  \nCover Page Interactive File (the cover page tags are embedded within the Inline XBRL document).\n\n \n\nSIGNATURE\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n \nBIODESIX, INC.\n\nDated: May 20, 2026\n \n\n \nBy:\n \n\n/s/ Robin Harper Cowie\n\n \n\n \nName:\n \nRobin Harper Cowie\n\n \n\n \nTitle:\n \nChief Financial Officer"}